Bull World Health Organ 2018;96:450–461 | doi: http://dx.doi.org/10.2471/BLT.17.206466
The aim of our study was to determine whether an intervention designed
to involve the male partners of pregnant women in Burkina Faso in facility-based maternity care influences care-seeking and healthy practi...ces after childbirth.
more
Le présent document qui fait suite à la recommandation ci-dessus citées se veut une
traduction de l’objectif n°4 du Plan National de Développement Sanitaire (PNDS)3
. Il
traduit la volonté du gouvernement burkinabé de développer un cadre de référence
pour tout intervenant dans le dom...aine de la qualité des prestations de services de
santé.
Il est le fruit d’une collaboration entre le Ministère de la santé et l’Organisation
Mondiale de la santé (OMS)
more
Livre I : Dispositions générales
Livre II : Protection générale et promotion de la santé publique
Livre III : Professions de santé et leur régime juridique
Livre IV : Produits pharmaceutiques, autres produits et pharmacopée traditionnelle
Livre V : Dispositions finales
Orientations provisoires, 16 novembre 2020
Ce document d’orientation a été conçu à l’intention des autorités nationales chargées de gérer le déploiement, la mise en œuvre et le suivi des vaccins contre la COVID-19, ainsi que des partenaires qui fourniss...ent le soutien nécessaire. Comme, dans la plupart des pays, la mise en place d’un mécanisme de déploiement et de vaccination du vaccin contre la COVID-19 relève du ministère de la santé, ce document vise à soutenir les pays dans l’élaboration de mécanismes de coordination entre tous les secteurs de leur gouvernement et entre les différentes parties prenantes.
more
Цель данной аналитической записки – предоставить краткое изложение информации и соображений,
касающихся принятия оптимальных мер в отношении гриппа во время па...демии COVID-19. В документе
рассматриваются первостепенные вопросы, с которыми могут столкнуться директивные органы, в том числе
вероятность одновременной циркуляции вирусов гриппа и SARS-CoV-2, дифференциальная диагностика
гриппа и COVID-19 у пациентов, а также планирование мероприятий по профилактике и борьбе с гриппом.
Кроме того, в документе содержатся ссылки на подробные технические рекомендации и другие ресурсы,
посвященные мерам, которые в одинаковой степени значимы как для борьбы с гриппом, так и COVID-19, в том
числе мониторинг ситуации, профилактика сезонного гриппа, снижение частоты случаев тяжелых осложнений
и летального исхода, охрана здоровья отдельных групп населения, а также взаимодействие и привлечение к
участию общественности. Influenza preparedness during the COVID-19 pandemic
more
Presentations and agenda of the meeting held to update industry on the COVAX Facility and Gavi’s support for cold chain equipment (CCE) for COVID-19 vaccines.
Explainer for countries based on commonly asked questions
12 November 2020
This document aims to explain how COVAX vaccines will be allocated amongst participants.
MEDBOX Issue Brief no.9 ,1 Febr. 2021
The Country Readiness and Delivery(CRD) workstream which is part of the ACT Accelerator and is included in the SPRP– has developed a toolbox with guidance, tools and training.
This catalogue provides tools and information resources to support EU/EEA countries in addressing the challenging issue of vaccine hesitancy. The catalogue provides examples of practices that can serve as a resource for other countries. The project was developed in the context of ECDC’s support fo...r EU/EEA Member States in prevention and control of vaccine-preventable diseases, including effective communication to promote immunisation.
more
The authors state that researchers, governments and global agencies should proceed with particular care in the evaluation of candidate SARS-CoV-2 vaccines in LMICs, with effective communication to build trust and avoid generation of vaccine hesitancy. Vaccine efficacy is often highly variable betwee...n high-resource and low-resource settings
Archives of Disease in Childhood, vol.106 Issue 2
more
How far apart should the doses of vaccines be? What if I miss my second dose? Can I get two doses from two different manufacturers? How was safety of vaccines ensured? WHO’s Chief Scientist, Dr Soumya Swaminathan explains in Science in 5.
Vaccines 2021, 9(2), 160; https://doi.org/10.3390/vaccines9020160
Social Media + SocietyJuly-September 2020: 1 –4
Обновленная версия Декабрь 2020 г.
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...-19 simulation exercises to test deployment strategies;
the indemnity agreement and no-fault compensation programme for vaccines secured through the COVAX Facility in the Advance Market Commitment (AMC) eligible economies;
the availability and use of the WHO-UNICEF COVID-19 Vaccine Introduction and deployment Costing (CVIC) tool;
the COVAX Facility’s humanitarian buffer that enables allocation of vaccine to cover high-risk populations in humanitarian settings;
recommendations for vaccination of pregnant and lactating women;
supplementary information on infection prevention and control (IPC) measures to be used to deliver COVID-19 vaccines safely;
the WHO licensed COVID-19 vaccines product-specific information;
use of geospatial data and digital micro plans for equitable access and delivery of COVID-19 vaccines;
lessons learned from the development of NDVPs and early experiences in COVID-19 vaccine deployment in countries; and
updated additional resources at the end of each chapter.
more